Venticute in Patients With Pneumonia or Aspiration of Gastric Contents and Intubation/Ventilation/Oxygenation Impairment (BY2001/M1-007)
Phase 3
Completed
- Conditions
- Pneumonia
- Registration Number
- NCT00074906
- Lead Sponsor
- Takeda
- Brief Summary
Study to demonstrate that administration of Venticute increases survival of patients with pneumonia or aspiration of gastric contents leading to intubation, mechanical ventilation, and severe oxygenation impairment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1200
Inclusion Criteria
Not provided
Read More
Exclusion Criteria
Not provided
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Survival on day 28 28 days
- Secondary Outcome Measures
Name Time Method How long the lung and the patient (overall) are recovering 28 days
Trial Locations
- Locations (1)
Altana Pharma/Nycomed
🇬🇧West Lothian, United Kingdom